About Cholangiocarcinoma

Cholangiocarcinoma is cancer of the bile ducts — the narrow tubes that carry bile from the liver to the small intestine. It is a rare cancer, accounting for roughly 3% of gastrointestinal cancers, and is challenging to diagnose and treat.

Unlike many other cancers, cholangiocarcinoma is classified primarily by its anatomic location, because the location determines the type of surgery required, the staging system used, and the overall treatment approach.

Surgical resection is the only treatment that offers a chance of cure. Because the surgery required is among the most complex in all of abdominal surgery, care at a high-volume hepatobiliary center is strongly recommended.

Hilar (Perihilar) — ~60%Klatskin tumor; at bifurcation of hepatic ducts; major liver + bile duct resection
Distal — ~25%In the common bile duct near pancreatic head; treated with Whipple (pancreaticoduodenectomy)
Intrahepatic — ~15%Arises within the liver; managed like a primary liver tumor with hepatic resection

Symptoms & Diagnosis

Cholangiocarcinoma often presents with obstructive jaundice when it involves the biliary system. Intrahepatic tumors may be found incidentally or present with non-specific symptoms.

Common Symptoms

  • Jaundice (yellowing of skin and eyes)
  • Dark urine and pale or clay-colored stools
  • Itching (pruritus)
  • Abdominal pain, often in the right upper quadrant
  • Unexplained weight loss and fatigue
  • Fever (if cholangitis from biliary obstruction)

Diagnostic Workup

  • High-quality MRI with MRCP (MRI cholangiopancreatography)
  • CT scan with vascular phase (for resectability assessment)
  • Serum CA 19-9 and CEA
  • Biliary drainage via percutaneous transhepatic drain (PTC) or ERCP — planning should involve a surgeon before drainage is performed
  • Endoscopic ultrasound (EUS) in select cases
  • PET scan to evaluate for distant disease

Types of Resection

Surgical approach depends on the location of the tumor. All operations require complete (R0) removal of the tumor with clear margins — even narrow margins significantly affect outcomes.

Resection for Klatskin Tumor

Requires resection of the bile duct confluence, major hepatectomy (right or left lobe), caudate lobe resection, and portal lymphadenectomy. Bile duct reconstruction is performed with a Roux-en-Y hepaticojejunostomy. This is one of the most demanding operations in abdominal surgery. Preoperative biliary drainage (preferably percutaneous) and portal vein embolization are often required. Drainage planning must involve a surgeon, as draining the wrong hepatic segment can cause cholangitis and compromise the surgical plan.

Pancreaticoduodenectomy (Whipple)

Distal cholangiocarcinoma is treated the same way as pancreatic head tumors — with the Whipple procedure. The operation removes the head of the pancreas, the duodenum, the distal bile duct, the gallbladder, and sometimes the distal stomach, followed by reconstruction of the digestive tract.

Hepatic Resection

Intrahepatic cholangiocarcinoma is treated like other liver tumors — surgical resection with adequate margins and portal lymphadenectomy. The extent of resection depends on the size and location. Future liver remnant calculation and portal vein embolization may be needed for large tumors requiring major hepatectomy.

Preoperative biliary drainage is often required before surgery when a patient presents with jaundice. Normalizing bilirubin reduces operative risk — but how drainage is performed, which side is drained, and how completely it is drained must be planned with surgery in mind. Draining the wrong side or achieving incomplete drainage can cause cholangitis and create significant delays or complications that affect surgical eligibility. These decisions are best made through a multidisciplinary discussion that includes a hepatobiliary surgeon before any drainage procedure is scheduled. Percutaneous transhepatic drainage (PTD) is preferred in most cases of hilar cholangiocarcinoma.

Frequently Asked Questions

What is cholangiocarcinoma?
Cholangiocarcinoma is cancer of the bile ducts. It is classified by location: intrahepatic (inside the liver), hilar/perihilar (at the junction of the left and right hepatic ducts — Klatskin tumor), and distal (near the pancreatic head). Each type is treated differently. Hilar cholangiocarcinoma is the most common and often requires major liver surgery combined with bile duct resection.
Why does bile duct cancer cause jaundice?
Tumors within the bile ducts obstruct the flow of bile from the liver into the intestine. When bile cannot drain normally, bilirubin accumulates in the blood, causing yellowing of the skin and eyes, dark urine, pale stools, and persistent itching. Biliary drainage is usually required before major surgery. Importantly, the decision to drain, which ducts to drain, and how to drain them should be made in consultation with a hepatobiliary surgeon before any procedure is performed — draining the wrong side or incompletely can cause cholangitis, delay surgery, or jeopardize resectability.
Is surgery the only curative option?
Surgical resection with negative margins is the only treatment that offers a chance of cure. Because many patients present at an advanced stage, only a minority are candidates for curative resection. Liver transplantation is an option for a highly select group with early hilar cholangiocarcinoma at specialized centers. Chemotherapy (gemcitabine/cisplatin ± immunotherapy) is standard for unresectable disease.
What does surgery for hilar (Klatskin) cholangiocarcinoma involve?
Surgery for Klatskin tumor typically requires resection of the bile duct confluence, major hepatectomy (right or left lobe), caudate lobe resection, regional lymphadenectomy, and reconstruction of the bile duct to a bowel loop (hepaticojejunostomy). This is among the most technically demanding operations in abdominal surgery and should be performed at a high-volume center.

Seek Expert Evaluation for Bile Duct Cancer

Cholangiocarcinoma requires subspecialty expertise. If you have been diagnosed or are seeking a second opinion on resectability, contact Dr. Correa's office.